CBC Group
PE/Buy-Out · Singapore (Singapore)
Sign up free to access full profile and submit your pitch.
About
CBC Group is a private equity and venture capital firm specializing in incubation, early stage, seed startup, growth capital, late stage, emerging growth, mature, and buyout investments. The fund typically invests in the healthcare sector with a focus on life sciences, med-tech, bio-technology, pharmaceuticals,IVD, mobile health care, medicine, diagnostics, medical services, and medical devices with a focus on investing in the treatment of Hepatitis B and lung cancer. The firm prefers to seek controlling acquisition opportunities and minority investment strategies in pharmaceutical and biotechnology, medical technology and medical services. It seeks to invest globally specifically in Asia-Pacific, especially China, the United States, and Israel. CBC Group was founded in 2014 and is based in Singapore, with additional offices in Asia and United States.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.
Co-Investors of CBC Group
Other investors that have backed the same portfolio companies as CBC Group. Expand any entry to see the shared portfolio companies.
- 4 shared
Shared portfolio companies
- 3 shared
Shared portfolio companies
- 3 shared
Shared portfolio companies
- Everest Medicines Limited
- NovaBridge Biosciences
- RVAC Medicines Pte. Ltd.
- 3 shared
Shared portfolio companies
- 3 shared
Shared portfolio companies
- NiKang Therapeutics, Inc.
- Nuance Biotech
- NUANCE BIOTECH INC
- 3 shared
- 3 shared
Shared portfolio companies
- NiKang Therapeutics, Inc.
- Nuance Biotech
- NUANCE BIOTECH INC
- 3 shared
Shared portfolio companies
- 2 shared
Shared portfolio companies
- 2 shared
Shared portfolio companies
- Hunan One-piece Pharmaceutical Technology Co., Ltd.
- Hunan Yikuai Yiyao Technology Co., Ltd.
